메뉴 건너뛰기
Cancer Chemotherapy and Pharmacology
Volumn 37, Issue 5, 1996, Pages 491-495
Gemcitabine: A phase II study in patients with advanced renal cancer
Author keywords

Gemcitabine; Metastatic disease; Renal cell cancer
Indexed keywords

GEMCITABINE;
EID: 0030049056     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050417     Document Type: Article
Times cited : (63)
References (10)
  • 1
    • 0021073165 scopus 로고
    • The natural history of renal cell carcinoma
    • Ritchie AWS, Chisholm GD (1983) The natural history of renal cell carcinoma. Semin Oncol 10:390-400
    • (1983) Semin Oncol , vol.10 , pp. 390-400
    • Ritchie, A.W.S.1    Chisholm, G.D.2
  • 2
    • 0023727132 scopus 로고
    • Prognostic factors in adult metastatic renal carcinoma: A multivariate analysis
    • De Forges A, Rey A, Klink M, et al (1988) Prognostic factors in adult metastatic renal carcinoma: a multivariate analysis. Semin Surg Oncol 4:149-154
    • (1988) Semin Surg Oncol , vol.4 , pp. 149-154
    • De Forges, A.1    Rey, A.2    Klink, M.3
  • 3
    • 0017361999 scopus 로고
    • The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma
    • Montie JE, Stewart BH, Straffon RA, et al (1977) The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J Urol 117:272-275
    • (1977) J Urol , vol.117 , pp. 272-275
    • Montie, J.E.1    Stewart, B.H.2    Straffon, R.A.3
  • 4
    • 0021013543 scopus 로고
    • Hormonal therapy and chemotherapy of renal cell carcinoma
    • Harris DT (1983) Hormonal therapy and chemotherapy of renal cell carcinoma. Semin Oncol 10:422-430
    • (1983) Semin Oncol , vol.10 , pp. 422-430
    • Harris, D.T.1
  • 5
    • 0024310179 scopus 로고
    • Failure of cytotoxic chemotherapy. 1983-1988, and the emerging role of monoclonal antibodies for renal cancer
    • Yagoda A, Bander NH (1989) Failure of cytotoxic chemotherapy. 1983-1988, and the emerging role of monoclonal antibodies for renal cancer. Urol Int 44:338-345
    • (1989) Urol Int , vol.44 , pp. 338-345
    • Yagoda, A.1    Bander, N.H.2
  • 6
    • 0021044876 scopus 로고
    • Immunologic therapies in kidney carcinoma
    • McCune CS (1983) Immunologic therapies in kidney carcinoma. Semin Oncol 10:431-436
    • (1983) Semin Oncol , vol.10 , pp. 431-436
    • McCune, C.S.1
  • 7
    • 0028266553 scopus 로고
    • Treatment of 238 consecutive patients with metatastatic melanoma or renal cell cancer using high-dose bolus interleukin-2
    • Rosenberg SA, Yang JC, Topalian SL, et al (1994) Treatment of 238 consecutive patients with metatastatic melanoma or renal cell cancer using high-dose bolus interleukin-2. JAMA 271:907-913
    • (1994) JAMA , vol.271 , pp. 907-913
    • Rosenberg, S.A.1    Yang, J.C.2    Topalian, S.L.3
  • 8
    • 0342868637 scopus 로고
    • Weekly gemcitabine: A phase I study with short and prolonged infusion schedules
    • Pollera CF, Ceribelli A, Grecco M, et al (1992) Weekly gemcitabine: a phase I study with short and prolonged infusion schedules (abstract). Proc Am Soc Clin Oncol 11:329
    • (1992) Proc Am Soc Clin Oncol , vol.11 , pp. 329
    • Pollera, C.F.1    Ceribelli, A.2    Grecco, M.3
  • 9
    • 9044244231 scopus 로고
    • Gemcitabine safety overview
    • Proceedings European Conference Clinical Oncology 7 Satellite Symposium. Jerusalem. Israel
    • Tonato M (1993). Gemcitabine safety overview. In: Gemcitabine novel combination of efficacy and tolerability. Proceedings European Conference Clinical Oncology 7 Satellite Symposium. Jerusalem. Israel, pp 14-16
    • (1993) Gemcitabine Novel Combination of Efficacy and Tolerability , pp. 14-16
    • Tonato, M.1
  • 10
    • 0027231510 scopus 로고
    • Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group
    • Mertens WC, Eisenhauer EA, Moore M, et al (1993) Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol 4:331-332
    • (1993) Ann Oncol , vol.4 , pp. 331-332
    • Mertens, W.C.1    Eisenhauer, E.A.2    Moore, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.